Since metformin can activate PGC-1α via the AMPK signaling pathway, it could be employed to enhance the mitochondrial fitness of precursor exhausted T cells to mitigate the exhaustion process and maintain their tumor-killing ability. This evidence concerns the gene PPARGC1A and neoplasm.